My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 720 / DOI: 10.3332/ecancer.2017.720

Case Report

CD19 (➕) CD56 (–) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia

Patients diagnosed with severe aplastic anaemia and without a compatible bone marrow transplant donor are treated with immunosuppressive therapy. These patients are found with time to develop a clonal disease such as myelodysplasia or paroxysmal nocturnal haemoglobinuria. However, the development of plasma cell dyscrasias is rare. We report the case here of a patient treated with immunosuppressive therapy who went on to develop myeloma 11 months after being diagnosed with severe aplastic anaemia. We include here a review of the literature.

Keywords: aplastic anemia, myeloma, immunosuppressive therapy

Loading Article Metrics ... Please wait

Related articles

Conference Report: Highlights of the twelfth annual meeting of the National Cancer Research Institute (NCRI), 6–9 November 2016, Liverpool, UK

Abstract | Full Article | PDF Published: 13 Feb 2017 / DOI: 10.3332/ecancer.2017.719

Review: An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management

Abstract | Full Article | PDF Published: 07 Dec 2016 / DOI: 10.3332/ecancer.2016.700

Case Report: Hepatic metastasis of thymoma: case report and immunohistochemical study

Abstract | Full Article | PDF | Spanish Published: 22 Nov 2016 / DOI: 10.3332/ecancer.2016.693

Case Report: The first case of benign multicystic mesothelioma presenting as a splenic mass

Abstract | Full Article | PDF Published: 04 Oct 2016 / DOI: 10.3332/ecancer.2016.678

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

Abstract | Full Article | PDF Published: 29 Sep 2016 / DOI: 10.3332/ecancer.2016.677



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence